Sunho Biologics, Inc. (HKG:2898)

Sunho Biologics Statistics

Total Valuation

Sunho Biologics has a market cap or net worth of HKD 1.07 billion. The enterprise value is 623.93 million.

Market Cap	1.07B
Enterprise Value	623.93M

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Sunho Biologics has 150.67 million shares outstanding. The number of shares has increased by 38.04% in one year.

Current Share Class	150.67M
Shares Outstanding	150.67M
Shares Change (YoY)	+38.04%
Shares Change (QoQ)	+43.02%
Owned by Insiders (%)	58.41%
Owned by Institutions (%)	n/a
Float	33.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	26,378.52
PB Ratio	1.96
P/TBV Ratio	2.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.33
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.95

Financial Position

The company has a current ratio of 11.17, with a Debt / Equity ratio of 0.08.

Current Ratio	11.17
Quick Ratio	10.54
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-0.28
Interest Coverage	-110.29

Financial Efficiency

Return on equity (ROE) is -39.21% and return on invested capital (ROIC) is -27.66%.

Return on Equity (ROE)	-39.21%
Return on Assets (ROA)	-14.88%
Return on Invested Capital (ROIC)	-27.66%
Return on Capital Employed (ROCE)	-19.62%
Revenue Per Employee	311
Profits Per Employee	-654,589
Employee Count	130
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.06% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+3.06%
50-Day Moving Average	5.60
200-Day Moving Average	4.70
Relative Strength Index (RSI)	93.38
Average Volume (20 Days)	6,840

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sunho Biologics had revenue of HKD 40,439 and -85.10 million in losses. Loss per share was -0.66.

Revenue	40,439
Gross Profit	40,439
Operating Income	-107.86M
Pretax Income	-85.10M
Net Income	-85.10M
EBITDA	-100.46M
EBIT	-107.86M
Loss Per Share	-0.66

Balance Sheet

The company has 486.63 million in cash and 43.84 million in debt, giving a net cash position of 442.79 million or 2.94 per share.

Cash & Cash Equivalents	486.63M
Total Debt	43.84M
Net Cash	442.79M
Net Cash Per Share	2.94
Equity (Book Value)	544.79M
Book Value Per Share	3.62
Working Capital	477.66M

Cash Flow

In the last 12 months, operating cash flow was -116.02 million and capital expenditures -41.90 million, giving a free cash flow of -157.91 million.

Operating Cash Flow	-116.02M
Capital Expenditures	-41.90M
Free Cash Flow	-157.91M
FCF Per Share	-1.05

Margins

Gross Margin	100.00%
Operating Margin	-266,720.70%
Pretax Margin	-210,431.86%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Sunho Biologics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.04%
Shareholder Yield	n/a
Earnings Yield	-7.98%
FCF Yield	-14.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sunho Biologics has an Altman Z-Score of 9.39 and a Piotroski F-Score of 1.

Altman Z-Score	9.39
Piotroski F-Score	1